The CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended lowering the pneumococcal vaccination age from 65 to 50, aiming to protect a broader population from potentially life-threatening pneumococcal diseases. This decision is based on the high incidence of these infections in adults aged 50-64, emphasizing the need for wider vaccine coverage.